Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agilon Health (AGL) Other Accumulated Expenses: 2020-2024

Historic Other Accumulated Expenses for Agilon Health (AGL) over the last 5 years, with FY2024 value amounting to $931.7 million.

  • Agilon Health's Other Accumulated Expenses fell 1102.47% to $1.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 billion, marking a year-over-year decrease of 1102.47%. This contributed to the annual value of $931.7 million for FY2024, which is 2628.9% up from last year.
  • As of FY2024, Agilon Health's Other Accumulated Expenses stood at $931.7 million, which was up 2628.9% from $737.7 million recorded in FY2023.
  • In the past 5 years, Agilon Health's Other Accumulated Expenses ranged from a high of $931.7 million in FY2024 and a low of $162.9 million during FY2020
  • Its 5-year average for Other Accumulated Expenses is $474.4 million, with a median of $300.8 million in 2022.
  • As far as peak fluctuations go, Agilon Health's Other Accumulated Expenses soared by 2584.95% in 2022, and later surged by 14525.56% in 2023.
  • Annual analysis of 5 years shows Agilon Health's Other Accumulated Expenses stood at $162.9 million in 2020, then surged by 46.75% to $239.0 million in 2021, then increased by 25.85% to $300.8 million in 2022, then surged by 145.26% to $737.7 million in 2023, then grew by 26.29% to $931.7 million in 2024.
  • Its Other Accumulated Expenses stands at $931.7 million for FY2024, versus $737.7 million for FY2023 and $300.8 million for FY2022.